These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


251 related items for PubMed ID: 23734600

  • 1. Familial nonmedullary thyroid carcinoma.
    Mazeh H, Sippel RS.
    Thyroid; 2013 Sep; 23(9):1049-56. PubMed ID: 23734600
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population.
    Uchino S, Noguchi S, Kawamoto H, Yamashita H, Watanabe S, Yamashita H, Shuto S.
    World J Surg; 2002 Aug; 26(8):897-902. PubMed ID: 11965446
    [Abstract] [Full Text] [Related]

  • 6. Familial nonmedullary thyroid carcinoma.
    Malchoff CD, Malchoff DM.
    Semin Surg Oncol; 1999 Aug; 16(1):16-8. PubMed ID: 9890735
    [Abstract] [Full Text] [Related]

  • 7. The long-term outcomes of the second generation of familial nonmedullary thyroid carcinoma are more aggressive than sporadic cases.
    Park YJ, Ahn HY, Choi HS, Kim KW, Park DJ, Cho BY.
    Thyroid; 2012 Apr; 22(4):356-62. PubMed ID: 22280228
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. An update on familial nonmedullary thyroid cancer.
    Ammar SA, Alobuia WM, Kebebew E.
    Endocrine; 2020 Jun; 68(3):502-507. PubMed ID: 32162184
    [Abstract] [Full Text] [Related]

  • 10. Endocrine tumours: familial nonmedullary thyroid carcinoma is a more aggressive disease: a systematic review and meta-analysis.
    Wang X, Cheng W, Li J, Su A, Wei T, Liu F, Zhu J.
    Eur J Endocrinol; 2015 Jun; 172(6):R253-62. PubMed ID: 25637073
    [Abstract] [Full Text] [Related]

  • 11. [Clinical and biological features of familial nonmedullary thyroid carcinoma].
    Gao J, Yu Y, Li X, Zhao J, Zhao C, Zhao J, Liu Y, Li Y, Gao M.
    Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):202-6. PubMed ID: 24785281
    [Abstract] [Full Text] [Related]

  • 12. The FOXE1 locus is a major genetic determinant for familial nonmedullary thyroid carcinoma.
    Bonora E, Rizzato C, Diquigiovanni C, Oudot-Mellakh T, Campa D, Vargiolu M, Guedj M, NMTC Consortium, McKay JD, Romeo G, Canzian F, Lesueur F.
    Int J Cancer; 2014 May 01; 134(9):2098-107. PubMed ID: 24127282
    [Abstract] [Full Text] [Related]

  • 13. Clinical behavior and genetics of nonsyndromic, familial nonmedullary thyroid cancer.
    Bauer AJ.
    Front Horm Res; 2013 May 01; 41():141-8. PubMed ID: 23652675
    [Abstract] [Full Text] [Related]

  • 14. Clinical features and genetic predisposition to hereditary nonmedullary thyroid cancer.
    Vriens MR, Suh I, Moses W, Kebebew E.
    Thyroid; 2009 Dec 01; 19(12):1343-9. PubMed ID: 20001717
    [Abstract] [Full Text] [Related]

  • 15. Clinicopathologic features of familial nonmedullary thyroid carcinoma.
    Fan YF, Zhang B, Yang X, Shang ZH, Liu HF, Xie Y, Liu YW, Gao WS, Wu Q, Li XY.
    Chin Med J (Engl); 2015 Apr 20; 128(8):1037-41. PubMed ID: 25881596
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.